​

Funding Round

Series A - PineTree Therapeutics

Series A - PineTree Therapeutics

Investment Firm

Overview

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Announced Date

Jul 30, 2024

Closed on Date

Jul 30, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

STIC Investment

STIC Investment

STIC Investment is a early_stage_venture and late_stage_venture and private_equity firm.

DSC Investment

DSC Investment

DSC Investment is a early_stage_venture and seed firm.

Participant Investors

6

Investor Name
Participant InvestorSchmidt
Participant InvestorSGI Venture Capital
Participant InvestorAtinum Partners
Participant InvestorDSC Investment
Participant InvestorSTIC Investment

Round Details and Background

PineTree Therapeutics raised $17000000 on 2024-07-30 in Series A

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 07, 2022
Series A - PineTree Therapeutics
6-23.5M
Sep 27, 2022
Grant - PineTree Therapeutics
1-undefined
Jul 30, 2024
Series A - PineTree Therapeutics
7-17.0M

Recent Activity

There is no recent news or activity for this profile.